Erasca to Present at the Guggenheim Oncology Conference 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
News
Erasca to Present at the Guggenheim Oncology Conference 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
Cogent Biosciences Announces Participation at Upcoming Investor Conferences
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Cogent Biosciences Announces Participation at Upcoming Investor Conferences
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Galecto to Participate in SVB Securities Global Biopharma Conference
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Galecto to Participate in SVB Securities Global Biopharma Conference
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Ocugen Appoints Quan A. Vu as Chief Business Officer
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Ocugen Appoints Quan A. Vu as Chief Business Officer
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer
Company plans to report interim data for the combination of UpRi with carboplatin in the second…
Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer
Company plans to report interim data for the combination of UpRi with carboplatin in the second…
GTG to form Strategic Alliance with global testing leader QIAGEN
MELBOURNE, Australia, Feb. 01, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”),…
GTG to form Strategic Alliance with global testing leader QIAGEN
MELBOURNE, Australia, Feb. 01, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”),…
Aleafia Health to Announce Fiscal Year 2023 Third Quarter Results
TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia…
Aleafia Health to Announce Fiscal Year 2023 Third Quarter Results
TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia…
BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (“BioStem” or the…
BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (“BioStem” or the…
Evelo Biosciences Provides Clinical and Business Updates
– Data from first three cohorts of EDP1815 Phase 2 trial in atopic dermatitis did…
Evelo Biosciences Provides Clinical and Business Updates
– Data from first three cohorts of EDP1815 Phase 2 trial in atopic dermatitis did…